Published on: December 04, 2019 at 10:30PM
Condition: Type 2 Diabetes
Interventions: Drug: SGLT2 inhibitor; Drug: GLP-1 receptor agonist
Sponsor: University of Padova
Completed
https://ift.tt/2rVkEZE
Wednesday, 4 December 2019
New diabetes clinical trial: Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.